Cannonau Stock Price, News & Analysis
Company Description
Cannonau (OTC Link: CNNC) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $48.3K.
CNNC stock has gained 50.0% over the past year. Shares last traded at $0.0003.
On a trailing twelve-month basis, Cannonau reported net income of $338K.
This page provides a comprehensive overview of CNNC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cannonau (CNNC) stock last traded at $0.0003. Over the past 12 months, the stock has gained 50.0%. At a market capitalization of $48.3K, CNNC is classified as a micro-cap stock with approximately 241.4M shares outstanding.
CNNC Rankings
Latest News
Cannonau has 8 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 0 with negative movement. View all CNNC news →
SEC Filings
Financial Highlights
operating income reached -$30K, and net income was $338K. The company generated -$32K in operating cash flow. With a current ratio of 0.02, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
CNNC Company Profile & Sector Positioning
Cannonau (CNNC) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CNNC often look at related companies in the same sector, including Owc Pharmaceutical Resh Corp (OWCP), Radiko Holdings (GEATF), Hero Technologies Inc (HENC), Emergent Health (EMGE), and Cannabis Stratgc (NUGS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CNNC's relative position within its industry.